NewAmsterdam Pharma Co N.V.

PERCEPTIVE ADVISORS LLC NAMS

Report date

3/31/2024

Quarter

2024 Q1

Filed

8/6/2024

Shares

175,000

Value ($000)

4,139

Weight

0.1%

2024 Q1 - 2024 Q1 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	8/6/2024	4,139	0.1%	175,000	3/31/2024